SIA
SGMO

Sit Investment Associates’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Sit Investment Associates’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-26,725
Closed -$155K – 463
2016
Q2 		$155K Hold
26,725
– – ﹤0.01% 399
2016
Q1 		$162K Hold
26,725
– – ﹤0.01% 406
2015
Q4 		$244K Hold
26,725
– – ﹤0.01% 392
2015
Q3 		$151K Hold
26,725
– – ﹤0.01% 420
2015
Q2 		$296K Hold
26,725
– – 0.01% 385
2015
Q1 		$419K Sell
26,725
-17,800
-40% -$275K 0.01% 367
2014
Q4 		$677K Sell
44,525
-3,480
-7% -$42.3K 0.01% 339
2014
Q3 		$518K Sell
48,005
-24,800
-34% -$324K 0.01% 371
2014
Q2 		$1.11M Buy
72,805
+24,750
+52% +$356K 0.02% 331
2014
Q1 		$869K Buy
+48,055
New +$926K 0.02% 358

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

Sit Investment Associates's SGMO Position: Q3 2016 in Review

Sit Investment Associates sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q3 2016, closing a stake of 26,725 shares — an estimated $155K sold.

Sit Investment Associates first reported a position in SGMO in Q1 2014 and held it in 10 quarters. The position peaked at $1.11M in Q2 2014. 124 funds tracked by Wall St. Rank hold SGMO as of Q3 2016.

  • Sit Investment Associates reported no remaining SANGAMO THERAPEUTICS INC position as of Q3 2016 after selling out during the quarter.
  • Sit Investment Associates sold 26,725 SANGAMO THERAPEUTICS INC shares in Q3 2016, an estimated $155K.
  • Sit Investment Associates first reported a position in SANGAMO THERAPEUTICS INC in Q1 2014 and held it in 10 quarters.
  • Sit Investment Associates's SANGAMO THERAPEUTICS INC position peaked at $1.11M in Q2 2014.
  • 124 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2016.

Based on Sit Investment Associates's 13F filing for Q3 2016, filed 1 Nov 2016.